Sunesis to Host Conference Call on July 27th to Discuss Second Quarter 2017 Financial Results and Recent Highlights
July 24 2017 - 7:00AM
Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today announced that it
will host a conference call on Thursday, July 27, 2017 at 2:00 p.m.
Eastern Time to discuss corporate updates and financial results for
the second quarter ended June 30, 2017.
The call can be accessed by dialing (844) 269-7720
(U.S. and Canada) or (574) 990-1148 (international), and entering
passcode 51914278.
To access the live audio webcast, or the subsequent
archived recording, visit the "Investors and Media - Calendar of
Events" section of the Sunesis website at http://ir.sunesis.com.
The webcast will be recorded and available for replay on the
company's website for two weeks.
About Sunesis
Pharmaceuticals
Sunesis is a biopharmaceutical company focused on
the development and commercialization of new oncology therapeutics
for the potential treatment of solid and hematologic cancers.
Sunesis has built a highly-experienced cancer drug development
organization committed to improving the lives of people with
cancer. Currently, the company is focused on advancing its novel
kinase-inhibitor pipeline, which includes its proprietary
non-covalent BTK-inhibitor, SNS-062.
For additional information on Sunesis, please
visit http://www.sunesis.com.
SUNESIS and the logos are trademarks
of Sunesis Pharmaceuticals, Inc.
Investor and Media Inquiries:
Maeve Conneighton
Argot Partners
212-600-1902
Dan Swisher
Sunesis Pharmaceuticals Inc.
650-266-3715
Sunesis Pharmaceuticals (NASDAQ:SNSS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Sunesis Pharmaceuticals (NASDAQ:SNSS)
Historical Stock Chart
From Apr 2023 to Apr 2024